COVID-19 mortality in the UK Biobank cohort: revisiting and evaluating risk factors
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-7284
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
COVID-19 mortality in the UK Biobank cohort: revisiting and evaluating risk factors ; day:15 ; month:2 ; year:2021 ; pages:1-11
European journal of epidemiology ; (15.2.2021), 1-11
- Creator
-
Elliott, Joshua
Bodinier, Barbara
Whitaker, Matthew
Delpierre, Cyrille
Vermeulen, Roel
Tzoulaki, Ioanna
Elliott, Paul
Chadeau-Hyam, Marc
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s10654-021-00722-y
- URN
-
urn:nbn:de:101:1-2021040419312612337159
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:51 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Elliott, Joshua
- Bodinier, Barbara
- Whitaker, Matthew
- Delpierre, Cyrille
- Vermeulen, Roel
- Tzoulaki, Ioanna
- Elliott, Paul
- Chadeau-Hyam, Marc
- SpringerLink (Online service)
Other Objects (12)
Is occupational physical activity associated with mortality in UK Biobank?
Vitamin D and COVID-19 infection and mortality in UK Biobank
Social connection and mortality in UK Biobank: a prospective cohort analysis
The role of obesity in mortality from digestive diseases in UK Biobank
Association between circadian physical activity patterns and mortality in the UK Biobank
Relationship between multimorbidity, demographic factors and mortality: findings from the UK Biobank cohort
Blood protein assessment of leading incident diseases and mortality in the UK Biobank
Predictors of mosaic chromosome Y loss and associations with mortality in the UK Biobank
Cardiovascular health and cancer mortality: evidence from US NHANES and UK Biobank cohort studies
Artificial sweeteners and risk of incident cardiovascular disease and mortality: evidence from UK Biobank
UK Biobank’s cardiovascular magnetic resonance protocol
Genetic variants are identified to increase risk of COVID-19 related mortality from UK Biobank data
Is occupational physical activity associated with mortality in UK Biobank?
Vitamin D and COVID-19 infection and mortality in UK Biobank
Social connection and mortality in UK Biobank: a prospective cohort analysis
The role of obesity in mortality from digestive diseases in UK Biobank
Association between circadian physical activity patterns and mortality in the UK Biobank
Relationship between multimorbidity, demographic factors and mortality: findings from the UK Biobank cohort
Blood protein assessment of leading incident diseases and mortality in the UK Biobank
Predictors of mosaic chromosome Y loss and associations with mortality in the UK Biobank
Cardiovascular health and cancer mortality: evidence from US NHANES and UK Biobank cohort studies
Artificial sweeteners and risk of incident cardiovascular disease and mortality: evidence from UK Biobank
UK Biobank’s cardiovascular magnetic resonance protocol
Genetic variants are identified to increase risk of COVID-19 related mortality from UK Biobank data
Is occupational physical activity associated with mortality in UK Biobank?
Vitamin D and COVID-19 infection and mortality in UK Biobank
Social connection and mortality in UK Biobank: a prospective cohort analysis
The role of obesity in mortality from digestive diseases in UK Biobank
Association between circadian physical activity patterns and mortality in the UK Biobank
Relationship between multimorbidity, demographic factors and mortality: findings from the UK Biobank cohort
Blood protein assessment of leading incident diseases and mortality in the UK Biobank
Predictors of mosaic chromosome Y loss and associations with mortality in the UK Biobank
Cardiovascular health and cancer mortality: evidence from US NHANES and UK Biobank cohort studies
Artificial sweeteners and risk of incident cardiovascular disease and mortality: evidence from UK Biobank
UK Biobank’s cardiovascular magnetic resonance protocol